Southeast AIDS Education and Training Center (SE AETC) | 615-875-7873

Webinar: HCV Treatment in 2016: Genotypes 1, 2, and 3

Webinar: HCV Treatment in 2016: Genotypes 1, 2, and 3

Webinar: HCV Treatment in 2016: Genotypes 1, 2, and 3 Facilitated by Cody Chastain, MD Assistant Professor, Viral Hepatitis Program Vanderbilt University School of Medicine, Division of Infectious Diseases October 12, 2016 Other Trainings Webinar: Watch Out! Drug Drug...
HCV Toolkit & Resources

HCV Toolkit & Resources

Hepatitis C (HCV) Toolkit Hepatitis C Virus (HCV) Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). Hepatitis C is a blood-borne virus. Today, most people become infected with the hepatitis C virus by sharing needles or other equipment to inject...
Valpatasvir/sofobuvir; a panacea for HCV?

Valpatasvir/sofobuvir; a panacea for HCV?

Valpatasvir/sofobuvir; a panacea for HCV? By: Takako Schaninger, MDAssociate Professor of Medicine | UK HealthCare This month, the FDA is expected to approve a new hepatitis C virus (HCV) drug. The once-daily, single-tablet, fixed-dose coformulation of velpatasvir and...
HCV Toolkit & Resources

Viral Hepatitis Project

Viral Hepatitis Project Hepatitis C Virus (HCV) Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). Hepatitis C is a blood-borne virus. Today, most people become infected with the hepatitis C virus by sharing needles or other equipment to inject...